154 related articles for article (PubMed ID: 31839704)
1. An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic Rats.
Ahmed TA; Mussari MA; Abdel-Hady SE; El-Say KM
Drug Des Devel Ther; 2019; 13():4035-4051. PubMed ID: 31839704
[TBL] [Abstract][Full Text] [Related]
2. Depot injectable atorvastatin biodegradable in situ gel: development, optimization, in vitro, and in vivo evaluation.
Ahmed TA; Alharby YA; El-Helw AR; Hosny KM; El-Say KM
Drug Des Devel Ther; 2016; 10():405-15. PubMed ID: 26855565
[TBL] [Abstract][Full Text] [Related]
3. Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for Anti-Hyperlipidemic Efficacy.
Kurakula M; Ahmed TA
Curr Drug Deliv; 2016; 13(2):211-20. PubMed ID: 26549039
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of lipid levels in triton induced hyperlipidemia rats through rosuvastatin calcium nanoparticles: Pharmacokinetic and pharmacodynamic studies.
Dudhipala NR; Ettireddy SR; Puchakayala GR
Chem Phys Lipids; 2021 Jul; 237():105081. PubMed ID: 33811848
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: Ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats.
Mahmoud MO; Aboud HM; Hassan AH; Ali AA; Johnston TP
J Control Release; 2017 May; 254():10-22. PubMed ID: 28344015
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
7. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
8. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers.
Rizwanullah M; Amin S; Ahmad J
J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665
[TBL] [Abstract][Full Text] [Related]
9. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
[No Abstract] [Full Text] [Related]
10. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
11. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
12. Formulation by design approach for development of ultrafine self-nanoemulsifying systems of rosuvastatin calcium containing long-chain lipophiles for hyperlipidemia management.
Beg S; Katare OP; Singh B
Colloids Surf B Biointerfaces; 2017 Nov; 159():869-879. PubMed ID: 28892871
[TBL] [Abstract][Full Text] [Related]
13. A PLGA-reinforced PEG in situ gel formulation for improved sustainability of hypoglycaemic activity of glimepiride in streptozotocin-induced diabetic rats.
Ahmed OAA; El-Say KM; Alahdal AM
Sci Rep; 2017 Nov; 7(1):16384. PubMed ID: 29180715
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacokinetics of celecoxib loaded endcapped PCLA-PEG-PCLA thermogels in rats after subcutaneous administration.
van Midwoud PM; Sandker M; Hennink WE; de Leede LGJ; Chan A; Weinans H
Eur J Pharm Biopharm; 2018 Oct; 131():170-177. PubMed ID: 30075312
[TBL] [Abstract][Full Text] [Related]
16. Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis.
Hosny KM; Rizg WY
PLoS One; 2018; 13(6):e0197540. PubMed ID: 29856752
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
[TBL] [Abstract][Full Text] [Related]
19. Cuboidal lipid polymer nanoparticles of rosuvastatin for oral delivery.
Suares D; Prabhakar B
Drug Dev Ind Pharm; 2017 Feb; 43(2):213-224. PubMed ID: 27593545
[TBL] [Abstract][Full Text] [Related]
20. PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide.
Al-Zuhairy SAS; Teaima MH; Shoman NA; Elasaly M; El-Nabarawi MA; El-Sawy HS
Drug Deliv; 2023 Dec; 30(1):2189112. PubMed ID: 36916128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
